We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

99 hedge funds and large institutions have $240M invested in SANGAMO THERAPEUTICS INC in 2013 Q2 according to their latest regulatory filings, with 99 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more call options, than puts

Call options by funds: $61.6M | Put options by funds: $3.97M

Holders
99
Holders Change
+99
Holders Change %
–
% of All Funds
3.23%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
99
Increased
–
Reduced
–
Closed
–
Calls
$61.6M
Puts
$3.97M
Net Calls
+$57.6M
Net Calls Change
+$57.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$41.9M +$46.8M +5,368,094 New
WA
2
Wasatch Advisors
Utah
$24.3M +$27.1M +3,108,482 New
State Street
3
State Street
Massachusetts
$21.2M +$23.7M +2,720,026 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$16M +$17.9M +2,049,100 New
BFA
5
BlackRock Fund Advisors
California
$14.4M +$16.1M +1,840,221 New
AWMDMG
6
Austin W. Marxe & David M. Greenhouse
New York
$13.8M +$15.4M +1,763,503 New
BIT
7
BlackRock Institutional Trust
California
$12.9M +$14.4M +1,647,125 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$11M +$12.3M +1,411,758 New
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$10.9M +$12.2M +1,400,000 New
Northern Trust
10
Northern Trust
Illinois
$6.4M +$7.15M +819,757 New
FC
11
FIC Capital
New York
$5.28M +$5.9M +676,096 New
TAM
12
Tiverton Asset Management
Delaware
$4.74M +$5.29M +606,800 New
Morgan Stanley
13
Morgan Stanley
New York
$4.68M +$5.23M +599,379 New
First Eagle Investment Management
14
First Eagle Investment Management
New York
$3.31M +$3.7M +424,350 New
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.26M +$3.64M +417,548 New
Bank of America
16
Bank of America
North Carolina
$2.77M +$3.09M +354,526 New
Allianz Asset Management
17
Allianz Asset Management
Germany
$2.52M +$2.81M +322,100 New
KIA
18
Kopp Investment Advisors
Minnesota
$2.5M +$2.8M +320,700 New
TCIM
19
TIAA CREF Investment Management
New York
$2.45M +$2.74M +313,555 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$2.04M +$2.28M +261,652 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$2.01M +$2.24M +256,954 New
AGA
22
Altrinsic Global Advisors
Connecticut
$1.87M +$2.09M +240,000 New
Goldman Sachs
23
Goldman Sachs
New York
$1.81M +$2.02M +231,557 New
Deutsche Bank
24
Deutsche Bank
Germany
$1.79M +$2M +229,043 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$1.72M +$1.92M +220,076 New
1
2 3 4

SGMO Hedge Fund Activity: Q2 2013 in Review

99 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2013, worth a combined $240M.

Buyers outnumbered sellers: 99 funds opened new SGMO positions and 0 closed out — a net gain of 99 holders — while 0 added to existing stakes and 0 trimmed.

  • 99 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $240M of SANGAMO THERAPEUTICS INC stock for Q2 2013.
  • 99 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2013 and 0 closed out, a net change of +99 holders.

Based on aggregated 13F filings for Q2 2013.